Radiofrequency resection of bronchial tumours in combination with cryotherapy: evaluation of a new technique.

Author:

Marasso A,Bernardi V,Gai R,Gallo E,Massaglia G M,Onoscuri M,Cardaci S B

Abstract

BACKGROUND: A number of treatments, including Nd-YAG laser therapy, brachytherapy, cryotherapy, electrocautery, and photodynamic therapy, can re-open the obstructed bronchial lumen in patients with inoperable obstructive bronchial tumours. None of these is considered to be a "gold standard". METHODS: The results of a retrospective study of 98 patients treated by radiofrequency tissue ablation and subsequent cryotherapy between January 1994 and June 1995 are reported. The patients were divided in two groups according to whether they were treated either after (group 1, n = 50) or before (group 2, n = 48) radiotherapy and/or chemotherapy. Bronchoscopic follow up was performed. The intervention was considered successful if the lumen was opened by > 80% and partially successful if it was opened by > 50%. RESULTS: In group 1 treatment was successful in 60%, partially successful in 32%, and unsuccessful in 8%. The median survival time was five months from the time of bronchoscopic surgery. In group 2 treatment was successful in 66%, partially successful in 21.5%, and unsuccessful in 12.5%, with a median survival time of 14 months from the time of bronchoscopic treatment. Forty patients (24 in group 1 and 16 in group 2) received a Dumon stent. CONCLUSIONS: Radiofrequency bronchoscopic surgery with cryotherapy appears to be a useful technique in the treatment of tracheobronchial obstruction.

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference17 articles.

1. Debulking was successful in 32 patients (66%), partially successful in 10 (21.5%), and unsuccessful in six (12.5%); 16 patients (10 with bronchial cancer and six with tracheal cancer) received a Dumon stent. Radiotherapy was performed in 42 patients (87.5%) within two weeks of cryotherapy at a mean dose of 50 Gy (range 30–60) and six (12.5%) received six cycles of chemotherapy (cyclophosphamide 100 mg/m2+etoposide 80 mg/m2), two for small cell lung cancer (SCLC) and four for NSCLC. Twenty eight died from disease progression with no local recurrence at the radiographic and bronchoscopic follow up. The median survival time was 14 months (range 2–18),1996

2. Nd-YAG laser in bronchoscopy: a five year experience with 1396 applications in 1000 patients;Cavaliere, S.; Foccoli, P.; Farina, P.L.;Chest,1988

3. Bronchoscopic management of tracheal lesions using the neodymium ytrium aluminium garnet laser;Toty, L.; Personne, C.; Colchen, A.; Vourch, G.;Thorax,1981

4. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma:a five years experience;Edell, E.S.; Cortese, D.A.,1987

5. Detection of early lung cancer using low dose photofrine II;Lam, S.; Palcic, B.; McLean, D.; Humg, J.;Chest,1990

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3